摘要
Nasim Sadat SADERI
药剂师
Consumer drivers and market opportunities in the expanding middle eastern aesthetic and cosmeceutical sector
Objectives: To identify the key factors influencing consumer demand and purchasing decisions for aesthetic treatments and cosmeceutical products in the Middle East and to evaluate how digital engagement and personalization affect practice performance and brand loyalty.
Introduction: The Middle East is experiencing rapid growth in aesthetic medicine and cosmeceuticals, driven by rising disposable income, a young demographic profile, and a strong cultural emphasis on appearance and wellness. Industry forecasts project annual market expansion above 8% through the next decade. Despite this momentum, few empirical studies have quantified consumer behavior or the business strategies most strongly associated with sustained clinic and brand growth across the region.
Materials / method: A mixed-methods study combined consumer surveys and expert interviews. Over six months, 1,800 adults in major Middle Eastern cities completed questionnaires on annual spending, willingness to pay for key product attributes, and attitudes toward tech-enabled personalization. Conjoint analysis measured trade-offs between clinical efficacy, ethical or religious certification, sustainability, and physician endorsement. Additionally, 25 clinic managers and distributors were interviewed to assess growth drivers.
Results: Median annual expenditure reached USD 1,450 (IQR 900–2,300). Clinical efficacy held the highest decision weight (34%), followed by ethical/religious certification (21%), physician endorsement (19%), and sustainability (13%). Willingness to pay rose 18% with AI-driven skin analysis or personalized formulations. Clinics using bilingual digital platforms and influencer collaborations saw 15% lower acquisition costs and higher 12-month retention than traditional channels.
Conclusion: The Middle Eastern aesthetic and cosmeceutical market offers exceptional growth potential. Businesses and clinics that integrate clinical credibility, culturally aligned branding, and AI-driven personalization—while maintaining agility in navigating regional regulations—are positioned to capture and sustain competitive advantage.
披露 - Nasim Sadat SADERI
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2026年 7月 30日 - Recorded during IMCAS Asia 2026